Abstract
Background Many developing countries struggle to attain equitable, timely and efficient availability of potent vaccines at the health facility level. In Uganda, several challenges prevent the reliable distribution of vaccines from the district vaccine store to the health facility level (last mile). The currently practiced mixed push and pull system mode of vaccine delivery is unpredictable, unreliable, and often presents issues of poor vaccine management, vaccine stock-outs and missed opportunities for vaccination.
The overall aim of the study was to improve the efficiency of the last mile delivery of vaccines by implementing an informed push model of vaccine delivery. Specifically, the study aimed to; improve vaccine lead time; standardise cold chain management practices during vaccine transportation; and cost the implementation of the informed push model.
Methods Mixed-methods approach to evaluate the impact of the informed push model on the last mile delivery of vaccines in Gomba district, Uganda was used. Quantitative and qualitative data was collected at baseline and endline. Quantitative data was collected on the mode, frequency, lead time and costs of vaccine delivery; vaccine stock status, and cold chain maintenance of vaccines during transportation using semi-structured interview survey, while the experiences and challenges were explored qualitatively using a guide. Analysis of quantitative data used descriptive statistics and that of costing data used an ingredients approach. Qualitative data using was analysed using a thematic framework.
Results The findings showed that the informed push system improved the efficiency and quality of vaccine delivery at the last mile in Gomba district. The average lead time of vaccine delivery was reduced from 14 days at baseline to 5 days by endline. The number of health facilities reporting timely receipt of vaccines increased from 36.8% at baseline to 100% by endline. Facilities reporting temperature monitoring of vaccines during transit improved from 26.3% at baseline to 100% by endline. Number of health facilities experiencing stock outs reduced from 79% at baseline to 36.8% by endline. The monthly costs incurred by health facilities in vaccine pick up at baseline were $ 170.8. The monthly costs for the informed push model were $445.9 ($ 0.06 per child reached) and more two and half times more than baseline costs of $170.8 incurred by health facilities during pick-up of vaccines from the district vaccine store.
Conclusion The study concluded that informed push model is a financially feasible strategy that could be efficient in improving the vaccine supply chain at the last mile by reducing lead time delivery of vaccines, improving vaccine cold chain management, reducing vaccine stock outs. We recommend the integration of this model into the national immunization program and its subsequent adoption by all districts in Uganda.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by East Africa Community Regional Centre of Excellence for Vaccine Immunization, and Health Supply Chain Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by Makerere University School of Public Health Higher degrees, Research and Ethics committee (SPH-2021-138: A) and the Uganda National Council of Science and Technology (HS2183ES).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data is available and has been uploaded
